NMPA Approval

Compound Paracetamol and Amantadine Hydrochloride Tablets

Approval Number

国药准字H52020845

Company贵州远程制药有限责任公司

Registration Date

November 15, 2019

Drug Information

Generic Name

复方氨酚烷胺片

Dosage Form

片剂

Strength

复方

Drug Type

化学药品

Registration Date

November 15, 2019

Company Information

Applicant Company

Company Name贵州远程制药有限责任公司

Manufacturing Company

Company Name贵州远程制药有限责任公司

Company Address

贵州省贵阳市乌当区高新北路5号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

复方氨酚烷胺片 - NMPA 批准文号 | MedPath